[ Price : $8.95]
Lilly CEO John Lichleiter writes in Forbes that the U.S. and EU should use upcoming trade negotiations to take steps to ease drug ...[ Price : $8.95]
Public Citizens Michael Carome says Congress should make the HHS Office of Human Research Protection an independent agency so it w...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Advanced MicroVas II, Descor, Health Science Products, John W. Hollis Inc., dba ...[ Price : $8.95]
Three organizations differ in their comments to FDA on whether biologics should have unique nonproprietary names.[ Price : $8.95]
Acura Pharmaceuticals files a formal dispute resolution request for Vycavert, an abuse-deterrent formulation of hydrocodone and ac...[ Price : $8.95]
Federal Register Proposed rule: FDA withdraws a proposed rule reclassifying the external pacemaker pulse generator devices.[ Price : $8.95]
Federal Register Proposed order: FDA proposes to reclassify the external pacemaker pulse generator devices into Class 2.[ Price : $8.95]
FDA accepts for review a Vernalis and Tris Pharma NDA for Tuzistra XR (CCP-01), an extended-release liquid said to be equivalent t...